IatroQuest
Ottawa
About IatroQuest
IatroQuest's breakthrough, patent-pending biosensing platform technology called Bio-Alloy™, is made possible by the convergence of nanotechnology, advanced semi-conductor materials, biotechnology and photonics. This Bio-Alloy platform will allow a wide range of product lines covering many market segments: from Biosensing Cartridges for the biodefense industry and high-density microarrays for drug discovery applications to Point-of-Care diagnostics and environmental monitoring. The unique attributes of Bio-Alloy™ enable it to detect and identify in real-time a wide range of biological agents, as well as specific small chemical molecules, with a high degree of sensitivity and selectivity.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $11.3M
- Last round: Series Unknown (Mar 2004)
- Website: iatroquest.com
- Phone: +1 (613) 740-0740
Industries & Categories
Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/iatroquest-1461963 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.